NT5E Inhibition Suppresses the Growth of Sunitinib-Resistant Cells and EMT Course and AKT/GSK-3β Signaling Pathway in Renal Cell Cancer

IUBMB Life - United States
doi 10.1002/iub.1942
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

βKlotho Suppresses Tumor Growth in Hepatocellular Carcinoma by Regulating Akt/GSK-3β/Cyclin D1 Signaling Pathway

PLoS ONE
Multidisciplinary
2013English

Cabozantinib Induces PUMA-dependent Apoptosis in Colon Cancer Cells via AKT/GSK-3β/NF-κB Signaling Pathway

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

Regulation of Akt/FOXO3a/GSK-3β/Ar Signaling Network by Isoflavone in Prostate Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

The Role of Akt/GSK-3β Signaling in Familial Hypertrophic Cardiomyopathy

Journal of Molecular and Cellular Cardiology
Cardiovascular MedicineMolecular BiologyCardiology
2009English

Resveratrol Modulates the Akt/GSK-3β Signaling Pathway in a Middle Cerebral Artery Occlusion Animal Model

Laboratory Animal Research
2019English

Resveratrol Suppresses Colon Cancer Growth by Targeting the AKT/STAT3 Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2018English

Dual Inhibition of BRD4 and PI3K-AKT by SF2523 Suppresses Human Renal Cell Carcinoma Cell Growth

Oncotarget
Oncology
2017English

BCL6B Suppresses Proliferation and Migration of Colorectal Carcinoma Cells Through Inhibition of the PI3K/AKT Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2018English

Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy